- Home
- MIST vs WIMI Comparison
MIST vs WIMI Comparison
Compare MIST & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- WIMI
- Stock Information
- Founded
- MIST 2003
- WIMI 2015
- Country
- MIST Canada
- WIMI China
- Employees
- MIST N/A
- WIMI N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- MIST Health Care
- WIMI Technology
- Exchange
- MIST Nasdaq
- WIMI Nasdaq
- Market Cap
- MIST 81.5M
- WIMI 97.0M
- IPO Year
- MIST N/A
- WIMI 2020
- Fundamental
- Price
- MIST $1.43
- WIMI $0.88
- Analyst Decision
- MIST Strong Buy
- WIMI
- Analyst Count
- MIST 3
- WIMI 0
- Target Price
- MIST $13.00
- WIMI N/A
- AVG Volume (30 Days)
- MIST 177.8K
- WIMI 408.8K
- Earning Date
- MIST 11-11-2024
- WIMI 01-01-0001
- Dividend Yield
- MIST N/A
- WIMI N/A
- EPS Growth
- MIST N/A
- WIMI N/A
- EPS
- MIST N/A
- WIMI N/A
- Revenue
- MIST N/A
- WIMI $84,137,968.00
- Revenue This Year
- MIST N/A
- WIMI N/A
- Revenue Next Year
- MIST N/A
- WIMI N/A
- P/E Ratio
- MIST N/A
- WIMI N/A
- Revenue Growth
- MIST N/A
- WIMI 19.25
- 52 Week Low
- MIST $1.12
- WIMI $0.56
- 52 Week High
- MIST $3.52
- WIMI $1.87
- Technical
- Relative Strength Index (RSI)
- MIST 42.50
- WIMI 47.40
- Support Level
- MIST $1.41
- WIMI $0.88
- Resistance Level
- MIST $1.53
- WIMI $0.90
- Average True Range (ATR)
- MIST 0.07
- WIMI 0.04
- MACD
- MIST -0.01
- WIMI -0.01
- Stochastic Oscillator
- MIST 26.96
- WIMI 26.76
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.